Swaerts, Koen
Dedeurwaerdere, Franceska
De Smet, Dieter
De Jaeger, Peter
Martens, Geert A. https://orcid.org/0000-0003-1208-6289
Article History
Received: 11 May 2022
Accepted: 14 February 2023
First Online: 1 March 2023
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki. The study was approved by the AZ Delta Ethical Committee (Clinical Trial Number/IRB B1172020000040, study 20126, approved on November 23, 2020). A waiver of informed consent was approved by the Ethical Committee AZ Delta (Commissie Medische ethiek AZ Delta) since the study relied only on the secondary use of next generation sequencing data on FFPE tumor specimens that were previously obtained as part of standard medical care.
: Not applicable.
: The authors declare that they have no competing interests.